Literature DB >> 25962575

Differential influence of propofol and isoflurane anesthesia in a non-human primate on the brain kinetics and binding of [(18)F]DPA-714, a positron emission tomography imaging marker of glial activation.

Wadad Saba1, Sébastien Goutal1, Bertrand Kuhnast1, Frédéric Dollé1, Sylvain Auvity1, Yoan Fontyn1, Jérôme Cayla1, Marie-Anne Peyronneau1, Héric Valette1, Nicolas Tournier1.   

Abstract

Translocator protein 18 kDa (TSPO) expression at the mitochondrial membrane of glial cells is related to glial activation. TSPO radioligands such as [(18)F]DPA-714 are useful for the non-invasive study of neuroimmune processes using positron emission tomography (PET). Anesthetic agents were shown to impact mitochondrial function and may influence [(18)F]DPA-714 binding parameters and PET kinetics. [(18) F]DPA-714 PET imaging was performed in Papio anubis baboons anesthetized using either intravenous propofol (n = 3) or inhaled isoflurane (n = 3). Brain kinetics and metabolite-corrected input function were measured to estimate [(18) F]DPA-714 brain distribution (VT). Displacement experiments were performed using PK11195 (1.5 mg/kg). In vitro [(18)F]DPA-714 binding experiments were performed using baboon brain tissue in the absence and presence of tested anesthetics. Brain radioactivity peaked higher in isoflurane-anesthetized animals compared with propofol (SUVmax = 2.7 ± 0.5 vs. 1.3 ± 0.2, respectively) but was not different after 30 min. Brain VT was not different under propofol and isoflurane. Displacement resulted in a 35.8 ± 8.4% decrease of brain radioactivity under propofol but not under isoflurane (0.1 ± 7.0%). In vitro, the presence of propofol increased TSPO density and dramatically reduced its affinity for [(18)F]DPA-714 compared with control. This in vitro effect was not significant with isoflurane. Exposure to propofol and isoflurane differentially influences TSPO interaction with its specific radioligand [(18)F]DPA-714 with subsequent impact on its tissue kinetics and specific binding estimated in vivo using PET. Therefore, the choice of anesthetics and their potential influence on PET data should be considered for the design of imaging studies using TSPO radioligands, especially in a translational research context.
© 2015 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  anesthetic; baboon; in vitro binding; neuroinflammation; peripheral benzodiazepine receptor; positron emission tomography

Mesh:

Substances:

Year:  2015        PMID: 25962575     DOI: 10.1111/ejn.12946

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  5 in total

Review 1.  Sifting through the surfeit of neuroinflammation tracers.

Authors:  Paul Cumming; Bjorn Burgher; Omkar Patkar; Michael Breakspear; Neil Vasdev; Paul Thomas; Guo-Jun Liu; Richard Banati
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-19       Impact factor: 6.200

2.  Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111.

Authors:  S Eberl; A Katsifis; M A Peyronneau; L Wen; D Henderson; C Loc'h; I Greguric; J Verschuer; T Pham; P Lam; F Mattner; A Mohamed; M J Fulham
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-04       Impact factor: 9.236

3.  Acute Morphine Exposure Increases the Brain Distribution of [18F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates.

Authors:  Sylvain Auvity; Wadad Saba; Sébastien Goutal; Claire Leroy; Irène Buvat; Jérôme Cayla; Fabien Caillé; Michel Bottlaender; Salvatore Cisternino; Nicolas Tournier
Journal:  Int J Neuropsychopharmacol       Date:  2017-01-01       Impact factor: 5.176

4.  Neuroinflammatory Changes in Relation to Cerebrospinal Fluid Viral Load in Simian Immunodeficiency Virus Encephalitis.

Authors:  Dima A Hammoud; Sanhita Sinharay; Swati Shah; William Schreiber-Stainthorp; Dragan Maric; Siva Muthusamy; Dianne E Lee; Cheri A Lee; Falguni Basuli; William C Reid; Paul Wakim; Kenta Matsuda; Vanessa Hirsch; Avindra Nath; Michele Di Mascio
Journal:  mBio       Date:  2019-05-28       Impact factor: 7.867

5.  Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation.

Authors:  Gloria Biechele; Tanja Blume; Maximilian Deussing; Benedikt Zott; Yuan Shi; Xianyuan Xiang; Nicolai Franzmeier; Gernot Kleinberger; Finn Peters; Katharina Ochs; Carola Focke; Christian Sacher; Karin Wind; Claudio Schmidt; Simon Lindner; Franz-Josef Gildehaus; Florian Eckenweber; Leonie Beyer; Barbara von Ungern-Sternberg; Peter Bartenstein; Karlheinz Baumann; Mario M Dorostkar; Axel Rominger; Paul Cumming; Michael Willem; Helmuth Adelsberger; Jochen Herms; Matthias Brendel
Journal:  Theranostics       Date:  2021-08-19       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.